Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Molecules (Basel, Switzerland)|March 17, 2011
Miniproteins as phage display-scaffolds for clinical applicationsFrederic Zoller, Uwe Haberkorn, Walter MierEuropean Journal of Pharmacology|October 20, 2009
Endoradiotherapy in cancer treatment--basic concepts and future trendsFrederic Zoller, Michael Eisenhut, Uwe Haberkorn, et al.Chemmedchem|January 4, 2012
Engineering and functionalization of the disulfide-constrained miniprotein min-23 as a scaffold for diagnostic applicationFrederic Zoller, Thimon Schwaebel, Annette Markert, et al.Bioorganic & Medicinal Chemistry Letters|May 30, 2009
[(68)Ga]Ga-DO(2)A-(OBu-l-tyr)(2): synthesis, (68)Ga-radiolabeling and in vitro studies of a novel (68)Ga-DO(2)A-tyrosine conjugate as potential tumor tracer for PETCarsten Burchardt, Patrick J Riss, Frederic Zoller, et al.Nuclear Medicine and Biology|December 26, 2012
Radiolabelling and preliminary evaluation of 68Ga-tetrapyrrole derivatives as potential tracers for PETFrederic Zoller, Patrick J Riss, Franz-Peter Montforts, et al.EJNMMI Research|June 8, 2012
A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancerMartin Schäfer, Ulrike Bauder-Wüst, Karin Leotta, et al.Angewandte Chemie (International Ed. in English)|November 15, 2012
Combination of phage display and molecular grafting generates highly specific tumor-targeting miniproteinsFrederic Zoller, Annette Markert, Philippe Barthe, et al.Molecules (Basel, Switzerland)|February 16, 2011
Challenges in optimizing a prostate carcinoma binding peptide, identified through the phage display technologyVasileios Askoxylakis, Sabine Zitzmann-Kolbe, Frederic Zoller, et al.Pageof 1